Expert gynecologic oncologist Ramez N. Eskander, MD, reviews the diagnosis and management of a 67-year-old woman with metastatic cervical cancer.
EP. 1: Navigating Complex Cervical Cancer Cases: Therapeutic Challenges and Innovations
Ramez N. Eskander, MD, discusses a challenging cervical cancer case, highlighting treatment advances and decision-making in recurrent and metastatic settings.
EP. 2: HPV and Cervical Cancer: Prevention and Screening Strategies
Expert insight into the pivotal role of HPV vaccines, evolving vaccination strategies, and advanced screening methods in cervical cancer prevention and management on a global scale.
EP. 3: Biomarkers in Cervical Cancer: Guiding Innovative Treatments
A key opinion leader explores the significance of biomarkers, including PD-L1 CPS score, TMB, MSI, and HER2, in shaping advanced treatment strategies for cervical cancer patients, emphasizing personalized care and clinical trial opportunities.
EP. 4: Revolutionizing Frontline Cervical Cancer Treatment: Trials to Transformative Therapies
An overview of the remarkable evolution in the treatment landscape for metastatic and recurrent cervical cancer patients, shaped by pivotal clinical trials and the integration of immunotherapy, resulting in significantly improved clinical outcomes.
EP. 5: Recurrent Cervical Cancer Treatment Evolution: Immunotherapy and Beyond
Ramez N. Eskander, MD, explores evolving treatment options, including immunotherapy and antibody drug conjugates, in recurrent cervical cancer, highlighting the importance of biomarkers and clinical trials in this dynamic landscape.
EP. 6: Tisotumab Vedotin: Advancing Cervical Cancer Treatment
Perspectives on the breakthrough antibody drug conjugate, tisotumab vedotin, its mechanism of action, and the significant clinical benefits it offers to patients with recurrent or metastatic cervical cancer, leading to FDA approval and promising results in a confirmatory trial.
EP. 7: Managing Treatment-Related Side Effects of Tisotumab Vedotin
Ramez N. Eskander, MD, discusses the importance of understanding and managing treatment-related adverse events, including ocular side effects, bleeding, and neuropathy, associated with the innovative therapy tisotumab vedotin in cervical cancer patients.
EP. 8: Innovations in Cervical Cancer Treatment: Exploring Tisotumab Vedotin Combinations
Discover the potential of tisotumab vedotin combinations and emerging treatment strategies in the evolving landscape of cervical cancer management.
2 Clarke Drive Cranbury, NJ 08512